Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
This article outlines budgeting strategies for large families, ensuring scalable allocation of funds and clear priorities across many members.
24,021 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
A dramatic rise in sandisk stock skyrocketed 857% in the first half of 2026 captured investors’ attention. This artic...
Carl Icahn’s latest stake move in Icahn Enterprises drew attention from investors. This article breaks down what icah...
Two popular growth focused ETFs, VUG and MGK, battle for your attention. This guide breaks down how mega leaders broa...
Stock splits grab headlines, but they don’t change a company’s fundamentals. This guide untangles why wall street's l...
Prescription drug costs can surprise even careful savers. This guide shares practical, real-world tactics to lower wh...
LNG demand is reshaping bets on natural gas, lifting producer-focused ETFs while futures-based funds lag. Analysts wa...
Agentic AI changes how data centers think and act. This guide breaks down AMD, ARM, and Intel to identify the intel: ...
California's governor signs a bold policy to curb insider moves in prediction markets. The move, framed as protecting...
On May 13, the stock market today showed energy storage equities rallying after solid earnings, then retreating as tr...
A niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
Solana just posted a landmark quarter with over $1 trillion in on-chain activity. This article unpacks what that mile...